Skip to main content
. 2018 Aug 15;11:1205–1217. doi: 10.2147/IDR.S171236

Figure 3.

Figure 3

Sepsis-related mortality of patients with MRSA bacteremia treated with teicoplanin, according to source of infection and maintenance dose (standard-dose or high-dose) after loading doses of teicoplanin.

Notes: Numbers of cases with survival or mortality in the respective group are indicated. Comparison between groups was performed using the χ2 test or Fisher’s exact test, as appropriate. The results are indicated as 2-tailed p-values, with p<0.05 being statistically significant.

Abbreviations: Bone & joint, bone and joint infection; Catheter, catheter-related infection; IAI, intra-abdominal infection; IE, infective endocarditis; MRSA, methicillin-resistant Staphylococcus aureus; PN, pneumonia; SSTI, skin and soft tissue infection; Unknown, no identified focus of infection; UTI, urinary tract infection.